Catalysts for Jiangsu Hengrui Pharmaceuticals Co Ltd
3 tracked
Apr 30, 2026
phase 1 2 completion
Jiangsu Hengrui Pharmaceuticals Co Ltd — adebrelimab (Phase I/II Trial Completion)
adebrelimab
→
Apr 27, 2026
phase 2 initiation
Jiangsu Hengrui Pharmaceuticals Co Ltd — fruquintinib (Phase II Trial Initiation)
fruquintinib
→
Apr 27, 2026
phase 2 initiation
Jiangsu Hengrui Pharmaceuticals Co Ltd — HRS-3738 (Phase II Trial Initiation)
HRS-3738
→